NEOG

Neogen Corporation

61
Fundamentals66/ 100
Valuation50/ 100
Upside potential60/ 100
Risk potential32/ 100

NEOG lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

NEOG Fundamentals

MetricStatus
Stable
Stable
Healthy
Weak

NEOG's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.

NEOG PE Valuation

NEOG has no meaningful PE right now: it lost money over the past year.

NEOG Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for NEOG, with profitability improving. However, they disagree widely on these estimates.

NEOG Risk to reward

ScenarioChangePrice
Upside+47%$16.50
Downside-32%$7.65

Calculated from the latest close: $11.19 on Nov 12.

NEOG's one-year upside scenario is somewhat larger than its downside: +47% against −32%.

NEOG Earnings Per Share

Q4 2023: $0.06Q1 2024: $0.01Q2 2024: $-0.04Q3 2024: $-0.11Q4 2024: $-2.19Q1 2025: $-2.23Q2 2025: $-5.03Q3 2025: $-4.80Q4 2025: $-2.77Q1 2026: $-2.80Q2 2026: $-0.04Q3 2026: $-0.26Forward: $0.34
Q4 2023: $0.06Q1 2024: $0.01Q2 2024: $-0.04Q3 2024: $-0.11Q4 2024: $-2.19Q1 2025: $-2.23Q2 2025: $-5.03Q3 2025: $-4.80Q4 2025: $-2.77Q1 2026: $-2.80Q2 2026: $-0.04Q3 2026: $-0.26Forward: $0.34
QuarterTTM EPSYoY
Forward$0.34—
Q3 2026-$0.26+$4.54
Q2 2026-$0.04+$4.99
Q1 2026-$2.80-$0.57
Q4 2025-$2.77-$0.58
Q3 2025-$4.80-$4.69
Q2 2025-$5.03-$4.99
Q1 2025-$2.23-22400%
Q4 2024-$2.19-3750%

NEOG is still losing money, but far less than before: $0.26 per share over the past year, against $5.03 at its worst in mid-2025.

NEOG Quarterly Revenue

Q4 2023: $230MQ1 2024: $229MQ2 2024: $237MQ3 2024: $217MQ4 2024: $231MQ1 2025: $221MQ2 2025: $225MQ3 2025: $209MQ4 2025: $225MQ1 2026: $211MQ2 2026: $225MQ3 2026: $223M
Q4 2023: $230MQ1 2024: $229MQ2 2024: $237MQ3 2024: $217MQ4 2024: $231MQ1 2025: $221MQ2 2025: $225MQ3 2025: $209MQ4 2025: $225MQ1 2026: $211MQ2 2026: $225MQ3 2026: $223M
QuarterRevenueYoY
Q3 2026$222.8M+6.5%
Q2 2026$225.3M-0.1%
Q1 2026$211.2M-4.4%
Q4 2025$224.7M-2.8%
Q3 2025$209.2M-3.6%
Q2 2025$225.5M-4.8%
Q1 2025$221M-3.4%
Q4 2024$231.3M+0.7%

NEOG's revenue grew through 2023 and has held roughly level since: $223M last quarter, up 6.5% from the same quarter a year ago.

NEOG Free Cash Flow

Q4 2023: −$9MQ1 2024: −$62MQ2 2024: $2MQ3 2024: −$56MQ4 2024: $23MQ1 2025: −$14MQ2 2025: $406,000Q3 2025: −$13MQ4 2025: $8MQ1 2026: $11MQ2 2026: $26MQ3 2026: $5M
Q4 2023: −$9MQ1 2024: −$62MQ2 2024: $2MQ3 2024: −$56MQ4 2024: $23MQ1 2025: −$14MQ2 2025: $406,000Q3 2025: −$13MQ4 2025: $8MQ1 2026: $11MQ2 2026: $26MQ3 2026: $5M
QuarterFree cash flowYoY
Q3 2026$4.7M+$17.8M
Q2 2026$26.2M+6353%
Q1 2026$11.1M+$24.6M
Q4 2025$7.8M-66%
Q3 2025-$13.1M+$43.2M
Q2 2025$406K-84%
Q1 2025-$13.5M+$48.8M
Q4 2024$23.1M+$31.8M

NEOG's free cash flow has turned positive after four years mostly in the red: $50M over the past year.

NEOG Total Shares

Q4 2023: 216MQ1 2024: 217MQ2 2024: 216MQ3 2024: 217MQ4 2024: 217MQ1 2025: 217MQ2 2025: 217MQ3 2025: 217MQ4 2025: 217MQ1 2026: 218MQ2 2026: 218MQ3 2026: 218M
Q4 2023: 216MQ1 2024: 217MQ2 2024: 216MQ3 2024: 217MQ4 2024: 217MQ1 2025: 217MQ2 2025: 217MQ3 2025: 217MQ4 2025: 217MQ1 2026: 218MQ2 2026: 218MQ3 2026: 218M
PeriodChange %Net change
Quarterly+0.3%+600K shares
1 year+0.4%+765K shares
3 years+0.6%+1.3M shares
5 years+102%+110M shares
Available history+106%+112M shares

NEOG has 218M diluted shares, about the same as a year ago.

NEOG Net Leverage

Q4 2023: 3.7xQ1 2024: 3.9xQ2 2024: 4.1xQ3 2024: 4.8xQ2 2026: 6.4xQ3 2026: 12.7x
Q4 2023: 3.7xQ1 2024: 3.9xQ2 2024: 4.1xQ3 2024: 4.8xQ2 2026: 6.4xQ3 2026: 12.7x
QuarterNet LeverageStatus
Q3 202612.7xHigh
Q2 20266.4xHigh
Q3 20244.8xHigh
Q2 20244.1xHigh
Q1 20243.9xElevated
Q4 20233.7xElevated
Q3 20234.4xHigh
Q2 20235.7xHigh

NEOG's net debt is about 13 years of its operating earnings (EBITDA), up from 3.9 years a year ago.

NEOG Weekly Momentum

MetricValueStatus
RSI50.8Neutral
Stochastic25.0Neutral

NEOG's weekly RSI is 51 (neutral) and its Stochastic is 25 (neutral).

NEOG PE vs Healthcare Sector

MetricNEOGSector medianRelative
PEN/A26x—

NEOG has no meaningful PE right now: it lost money over the past year.

NEOG Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.17.3% below
20 week MA$11.52.9% below
50 week MA$10.111% above
100 week MA$8.6230% above
200 week MA$12.913% below

NEOG's trend is mixed: it's above two of its five weekly moving averages, and 13% below its 200-week average.

NEOG Yearly ROI

YearStart priceEnd priceROI
2020$32.5$40.5+24%
2021$40.5$44.4+9.7%
2022$44.4$14.9-67%
2023$14.9$20.1+35%
2024$20.1$12.4-38%
2025$12.4$7.13-43%
2026 YTD$7.13$11.2+57%

NEOG is up 57% so far in 2026, after finishing lower in three of the previous six years.

Give your agent the market.

Get API key